Lobular neoplasia (LN) is a term that describes the continuum of atypical epithelial lesions
originating in the terminal duct-lobular unit (TDLU) of the breast. 1 To predict cancer risk …

BACKGROUND: The clinical management of lobular carcinoma in situ lesions remains
challenging. Our aim was to evaluate the risk of relapse for lobular carcinoma in situ (LCIS) …

Lobular carcinoma in situ and invasive lobular cancer of the... : Current Opinion in Obstetrics
and Gynecology Lobular carcinoma in situ and invasive lobular cancer of the breast : Current …

Recent reports suggest that the finding of lobular neoplasia (atypical lobular hyperplasia
[ALH] or lobular carcinoma in situ [LCIS]) in breast core needle biopsy specimens may be …

Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is
divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS …

Background The risk of breast cancer in young women diagnosed with atypical hyperplasia
and (LCIS) is not well defined. The objectives were to evaluate outcomes and to help …

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia are rare lesions, found
incidentally in breast biopsies. They have been regarded traditionally as high‐risk lesions …

The management of atypical lobular hyperplasia (ALH) on core biopsy remains
controversial. The upstaging rates after surgical excision vary. We reviewed our upgrade …

Introduction Lobular carcinoma in situ (LCIS), atypical ductal and lobular hyperplasia (AH)
increase breast cancer risk. We examined risk management recommendations (RMR) and …